HIGHLIGHTS
- who: Andrea Casiraghi et al. from the Department of Pharmaceutical Sciences, University of Milan, Via Luigi Mangiagalli, Milano, Italy have published the paper: Methylphenidate Analogues as a New Class of Potential Disease-Modifying Agents for Parkinson’s Disease: Evidence from Cell Models and Alpha-Synuclein Transgenic Mice, in the Journal: Pharmaceutics 2022, 14, 1595. of 22/09/2010
- what: The results presented above support that among the selected MPH derivatives, compound I-threo exhibited an improved ability to stimulate the functional αSyn/Syn III interaction.
- how: All the experiments were conducted during daylight . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.